Pharmacology : a patient-centered nursing process approach / Joyce LeFever Kee, Evelyn R. Hayes, Linda E. McCuistion.
Material type: TextPublisher: St. Louis, Missouri : Elsevier/Saunders, [2015]Copyright date: ©2015Edition: 8 e [edition]Description: xv, 971 pages : colour illustrations, portraits ; 28 cmContent type:- text
- unmediated
- volume
- 1455751480
- 9781455751488
- Pharmacology : A patient-centred nursing process approach
- 615.58 23
- RM301 .K44 2015
Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Book | North Campus North Campus Main Collection | 615.58 KEE (Browse shelf(Opens below)) | 1 | Available | A516361B | ||
Book | North Campus North Campus Main Collection | 615.58 KEE (Browse shelf(Opens below)) | 1 | Available | A526299B |
Previous edition has subtitle: "A nursing process approach.".
Includes bibliographical references and index.
Drug action: pharmaceutic, pharmacokinetic, and pharmacodynamic phases -- The drug approval process -- Cultural and pharmacogenetic considerations -- Drug interactions and over-the-counter drugs -- Drugs of abuse -- Herbal therapies -- Pediatric pharmacology -- Geriatric pharmacology -- Collaboration in community settings -- The role of the nurse in drug research -- The nursing process in patient-centered pharmacotherapy -- Safety and quality in pharmacotherapy -- Medication administration -- Medications and calculations -- Vitamin and mineral replacement -- Fluid and electrolyte replacement -- Nutritional support -- Adrenergic agonists and adrenergic blockers -- Cholinergic agonists and anticholinergics -- Central nervous system stimulants -- Central nervous system depressants -- Anticonvulsants -- Drugs for neurologic disorders: Parkinsonism and Alzheimer's disease -- Drugs for neuromuscular disorders: myasthenia gravis, multiple sclerosis, and muscle spasms -- Antiinflammatory drugs -- Nonopioid and opioid analgesics -- Antipsychotics and anxiolytics -- Antidepressants and mood stabilizers -- Penicillins and cephalosporins -- Macrolides, tetracyclines, aminoglycosides, and fluoroquinolones -- Sulfonamides --
Antituberculars, antifungals, peptides, and metronidazole -- Antivirals, antimalarials, and anthelmintics -- Drugs for urinary tract disorders -- HIV- and AIDS-related drugs -- Vaccines -- Anticancer drugs -- Targeted therapies to treat cancer -- Biologic response modifiers -- Drugs for upper respiratory disorders -- Drugs for lower respiratory disorders -- Cardiac glycosides, antianginals, and antidysrhythmics -- Diuretics -- Antihypertensives -- Anticoagulants, antiplatelets, and thrombolytics -- Antihyperlipidemics and peripheral vasodilators -- Drugs for gastrointestinal tract disorders -- Antiulcer drugs -- Drugs for eye and ear disorders -- Drugs for dermatologic disorders -- Endocrine drugs: pituitary, thyroid, parathyroid, and adrenal disorders -- Antidiabetics -- Female reproductive cycle I: pregnancy and preterm labor drugs -- Female reproductive cycle II: labor, delivery, and preterm neonatal drugs -- Postpartum and newborn drugs -- Drugs for women's reproductive health and menopause -- Drugs for men's health and reproductive disorders -- Drugs for disorders in women's health, infertility, and sexually transmitted infections -- Adult and pediatric emergency drugs -- Appendix A: Therapeutic drug monitoring -- Appendix B: Selected potential weapons of bioterrorism.
There are no comments on this title.